We are live on ! Find out more
CELG

Celgene Corp
CELG

Delisted

CELG was delisted on the 20th of November, 2019.

1,317 hedge funds and large institutions have $33.5B invested in Celgene Corp in 2018 Q4 according to their latest regulatory filings, with 163 funds opening new positions, 382 increasing their positions, 623 reducing their positions, and 195 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more funds holding in top 10

Funds holding in top 10: 3741 (+4)

10% less call options, than puts

Call options by funds: $1.24B | Put options by funds: $1.37B

3% less funds holding

Funds holding: 1,3641,317 (-47)

16% less first-time investments, than exits

New positions opened: 163 | Existing positions closed: 195

28% less capital invested

Capital invested by funds: $46.6B → $33.5B (-$13.1B)

39% less repeat investments, than reductions

Existing positions increased: 382 | Existing positions reduced: 623

Holders
1,317
Holders Change
-47
Holders Change %
-3.45%
% of All Funds
29.34%
Holding in Top 10
41
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+10.81%
% of All Funds
0.91%
New
163
Increased
382
Reduced
623
Closed
195
Calls
$1.24B
Puts
$1.37B
Net Calls
-$134M
Net Calls Change
+$221M
Name Holding Trade Value Shares
Change
Change in
Stake
KSCM
576
Kamunting Street Capital Management
Florida
$1.67M +$1.11M +15,000 +136%
ACC
577
Accident Compensation Corp
New Zealand
$1.67M +$1.42M +19,177 +282%
CAM
578
Chesapeake Asset Management
New York
$1.66M -$31.4K -425 -2%
Rafferty Asset Management
579
Rafferty Asset Management
New York
$1.65M -$440K -5,955 -19%
ASN
580
Advisory Services Network
Georgia
$1.63M -$589K -7,978 -24%
WS
581
Wedbush Securities
California
$1.63M -$433K -5,869 -19%
Marshall Wace
582
Marshall Wace
United Kingdom
$1.63M -$19M -257,717 -91%
ACM
583
AlphaCrest Capital Management
New York
$1.61M +$1.86M +25,200 New
CCP
584
Corient Capital Partners
California
$1.61M -$689K -9,331 -27%
LCM
585
Landscape Capital Management
New Jersey
$1.61M +$1.58M +21,372 +579%
AAM
586
Augustine Asset Management
Florida
$1.6M +$1.84M +24,957 New
CIA
587
Choate Investment Advisors
Massachusetts
$1.6M -$165K -2,237 -8%
SIC
588
Sigma Investment Counselors
Michigan
$1.59M -$83.8K -1,135 -4%
Capstone Investment Advisors
589
Capstone Investment Advisors
New York
$1.58M +$1.47M +19,974 +425%
HCMT
590
Highland Capital Management (Texas)
Texas
$1.58M
RBA
591
Richard Bernstein Advisors
New York
$1.57M
KC
592
Knuff & Co
California
$1.55M +$1.78M +24,165 New
PFM
593
Parsec Financial Management
North Carolina
$1.51M +$383K +5,190 +28%
PHIMC
594
Private Harbour Investment Management & Counsel
Ohio
$1.5M +$316K +4,287 +22%
IP
595
Intellectus Partners
California
$1.5M -$319K -4,322 -16%
HCA
596
Horan Capital Advisors
Ohio
$1.49M -$340K -4,607 -17%
MLIC
597
Mandatum Life Insurance Company
Finland
$1.49M
HL
598
HeadInvest LLC
Maine
$1.48M +$107K +1,450 +7%
CSS
599
Cubist Systematic Strategies
Connecticut
$1.48M -$7.47M -101,236 -81%
11A
600
10-15 Associates
New York
$1.47M -$70.9K -960 -4%

CELG Hedge Fund Activity: Q4 2018 in Review

1,317 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q4 2018, worth a combined $33.5B — down 28% from $46.6B a quarter earlier.

Sellers outnumbered buyers: 195 funds closed out of CELG and 163 opened new positions — a net loss of 32 holders — while 623 trimmed existing stakes and 382 added.

The largest buyer was Millennium Management, adding an estimated $379M. The largest seller was Edgewood Management, cutting an estimated $1.16B.

  • 1,317 institutional investors held Celgene Corp (CELG) as of Q4 2018, down from 1,364 in Q3 2018.
  • Funds reported $33.5B of Celgene Corp stock for Q4 2018, down 28% quarter-over-quarter.
  • 163 funds opened new Celgene Corp positions in Q4 2018 and 195 closed out, a net change of -32 holders.
  • The largest Celgene Corp buyer in Q4 2018 was Millennium Management, an estimated $379M added.
  • The largest Celgene Corp seller in Q4 2018 was Edgewood Management, an estimated $1.16B sold.

Based on aggregated 13F filings for Q4 2018.